Results show limited survival advantage, only in specific patient types
Vienna, Austria, Friday 16th April 2010: Results from two studies presented today at the International Liver Congress™ 2010 have shown that treatment with extracorporeal devices may not confer a survival advantage for severe liver failure patients, despite positive dialysis effects. However, results among a small sub-group of patients show promise.
Full details can be dowloaded below.
